Gene Tekmyster, DO
Sports Medicine · El Segundo, CANPI 1316258304
Payments from drug & device makers
Across 135 payments — averaging $243.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$20K
- Vertiflex, Inc.$9K
- Relievant Medsystems, Inc.$1K
- Abbott$737
- Stryker$616
- Saluda Medical Americas, Inc.$185
- plus $897 from 8 others
What the payments were for
- Consulting fees$8,57527%
- Speaking & faculty fees$15,12548%
- Travel & lodging$2,2747%
- Food & beverage$5,80618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 54 | $20,067 |
| Vertiflex, Inc. | 20 | $9,012 |
| Relievant Medsystems, Inc. | 15 | $1,315 |
| Abbott | 17 | $737 |
| Stryker | 7 | $616 |
| Saluda Medical Americas, Inc. | 1 | $185 |
| MML US, Inc. | 7 | $171 |
| Globus Medical(2 entities) | 2 | $155 |
| Biotronik NRO, Inc. | 1 | $148 |
| Pacira Therapeutics, Inc. | 3 | $148 |
| Nevro Corp. | 2 | $136 |
| Curonix LLC | 3 | $82 |
| Medtronic | 2 | $37 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$9,900
- Superion ISS$7,620
- Intracept$4,696
- WaveWriter Alpha Prime 16$4,400
- mild Device Kit$290
- Evoke$185
- Prospera$148
- Proclaim IPG$138
- PROCLAIM$133
- Zilretta$125
- Senza$119
- SPECTRA WAVEWRITER$117
- GENERAL PAIN MANAGEMENT$113
How this compares
$32,830 in reported general payments places this provider in the 80th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 62 | $2,555 |
| Pregabalin | 52 | $976 |
| Gabapentin | 74 | $724 |
| Tramadol Hcl | 47 | $632 |
| Duloxetine Hcl | 16 | $203 |
| Meloxicam | 12 | $115 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $99 |
| Methylprednisolone | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in El Segundo
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Seth ShermanStanford$1.8M
- Michael FreehillStanford$1.7M
- Deryk JonesSan Carlos$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Marc SafranPalo Alto$1.2M
- Stephan YacoubianBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.